Skip to content

Siddha Intervention Population Study.

A prospective non-randomised open label controlled interventional study on the e ffe ct of Siddha intervention as a prophylactic measure among high risk population (Health Care Workers/ Containment Zone population) exposed to COVID 19

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025298
Enrollment
21500
Registered
2020-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Kabasurakudineer Nilavembukudineer: Siddha official formulation once daily for 14 days. Control Intervention1: Personal Sanitation and Environmental Sanitataion: Sanitisers Handwash M

Sponsors

Central council for research in Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult Male or Female subjects above the age of 5 years to 68 years 2. Subjects who are from a community where at least 1 confirmed case is already identified. 3. Subjects who are ready to provide written/digital informed consent and who are willing to participate and follow the protocol requirements of the clinical study

Exclusion criteria

Exclusion criteria: Pregnant and Lactating females Known cases of uncontrolled Diabetes and Hypertension COPD or Lung related diseases Subjects having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening 4. Subjects having immune compromised status like HIV Hepatitis Tuberculosis Cancer etc. 5. Subjects taking Steroid treatment and or any kind of immunosuppressive therapy 6. Subjects participating in any other clinical study or having participated in any other study 1 month prior to screening in the present study. 7. Subjects having a past history of allergy to any medicine that is part of the Siddha intervention. 8. Other conditions, which in the opinion of the investigators, makes the patient unsuitable for enrolment or could interfere with his participation in and completion of the protocol

Design outcomes

Primary

MeasureTime frame
1. Comparative assessment of occurrence of COVID-19 infection in healthy volunteers in community having at least 1 confirmed case already identified with control arm of Standard Prophylactic CareTimepoint: 1stweek 2ndweek 3rd week and 4th week

Secondary

MeasureTime frame
Assessment of side effects non hospitalization no severe symptoms no ventilatory support no of days in ICUTimepoint: 1stweek 2ndweek 3rd week and 4th week

Countries

India

Contacts

Public ContactDrKKanakavalli

siddha central research Institute

drkkanakavalli@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026